RT Journal Article
T1 [Management of hyperglycaemia with non-insulin drugs in adult patients with type 2 diabetes].
T2 Manejo de la hiperglucemia con fármacos no insulínicos en pacientes adultos con diabetes tipo 2.
A1 Álvarez-Guisasola, Fernando
A1 Orozco-Beltrán, Domingo
A1 Cebrián-Cuenca, Ana M
A1 Ruiz Quintero, Manuel Antonio
A1 Angullo Martínez, Escarlata
A1 Ávila Lachica, Luis
A1 Ortega Millán, Carlos
A1 Caride Miana, Elena
A1 Navarro-Pérez, Jorge
A1 Sagredo Perez, Julio
A1 Barrot de la Puente, Joan
A1 Cos Claramunt, Francesc Xavier
K1 Antidiabetic drugs
K1 Diabetes tipo 2
K1 Fármacos antidiabéticos
K1 Hiperglucemia
K1 Hyperglycemia
K1 Type 2 diabetes
AB Treatment of diabetes mellitus type2 (DM2) includes healthy eating and exercise (150minutes/week) as basic pillars. For pharmacological treatment, metformin is the initial drug except contraindication or intolerance; in case of poor control, 8 therapeutic families are available (6 oral and 2 injectable) as possible combinations. An algorithm and some recommendations for the treatment of DM2 are presented. In secondary cardiovascular prevention, it is recommended to associate an inhibitor of the sodium-glucose cotransporter type 2 (iSGLT2) or a glucagon-like peptide-1 receptor agonist (arGLP1) in patients with obesity. In primary prevention if the patient is obese or overweight metformin should be combined with iSGLT2, arGLP1, or inhibitors of type4 dipeptidylpeptidase (iDPP4). If the patient does not present obesity, iDPP4, iSGLT2 or gliclazide, sulfonylurea, recommended due to its lower tendency to hypoglycaemia, may be used.
YR 2019
FD 2019-07-15
LK http://hdl.handle.net/10668/14259
UL http://hdl.handle.net/10668/14259
LA es
DS RISalud
RD Apr 6, 2025